Zolmitriptan.

PubMed · 10386213

Zolmitriptan.

Abstract

*Zolmitriptan (Zomig) is an antimigraine drug similar to sumatriptan.*The clinical file mainly comprises placebo-controlled, dose-finding studies recommending an optimal oral dose of 2.5 mg.*Zolmitriptan has been compared with sumatriptan in a trial that showed no difference in efficacy. In particular, the recurrence rate of headache after initial relief was not lower on zolmitriptan than on sumatriptan.*The safety profile of zolmitriptan is similar to that of sumatriptan. The contraindications relating to a history of cardiovascular disease must be respected because of the vasoconstrictive effect of the drug.*Zolmitriptan has the same drug interactions as sumatriptan. Zolmitriptan should not be used during migraine attacks by patients using propranolol.

Explore related subjects

Drug Interactions Humans Migraine Disorders Oxazoles Oxazolidinones Serotonin Receptor Agonists Sumatriptan Tryptamines Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

1999. Zolmitriptan.. https://pubmed.ncbi.nlm.nih.gov/10386213/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

[Viral infections in renal transplantation].

KIDNEY TRANSPLANTATION IN HIV-POSITIVE SUBJECTS: To date, HIV+ patients have generally been excluded from transplantation programs. Encouraging results have however been obtained in 6 patients suggesting that transplantation and the accompanying immunosuppression are feasible in selected HIV-positive patients. HUMAN POLYOMAVIRUS INFECTIONS: Polyomavirus BK has been implicated as the pathogenic agent causing tubulointerstitial nephropathies in less than 5% of all kidney graft recipients. Polyomavirus JC, the causal agent of progressive multifocal leucoencephalitis, appears to be a co-infectant with the BK virus. Its pathogenic potential remains to be elucidated. POLYOMAVIRUS-LINKED PROBLEMS: It is very difficult to make the histological diagnosis of polyomavirus nephropathy due to the presence of several disease stages: the basic question is to distinguish between acute rejection and BK virus nephropathy. Excessive immunosuppression appears to be an predominant factor leading to BK virus infection of the kidney graft, sometimes leading to loss of the graft. It is thus a general rule to reduce the immunosuppression in patients with BK virus nephropathy. EPSTEIN-BARR VIRUS INFECTIONS: Epstein-Barr infections often lead to posttransplantation lymphoproliferative disorders that can be diagnosed early using quantitative polymerase chain reaction (PCR). PCR is also useful for measuring viral load and for adapting treatment.

Drug Interactions↗

PubMed2001

Oxazolidinones mechanism of action: inhibition of the first peptide bond formation.

Oxazolidinones are potent inhibitors of bacterial protein biosynthesis. Previous studies have demonstrated that this new class of antimicrobial agent blocks translation by inhibiting initiation complex formation, while post-initiation translation by polysomes and poly(U)-dependent translation is not a target for these compounds. We found that oxazolidinones inhibit translation of natural mRNA templates but have no significant effect on poly(A)-dependent translation. Here we show that various oxazolidinones inhibit ribosomal peptidyltransferase activity in the simple reaction of 70 S ribosomes using initiator-tRNA or N-protected CCA-Phe as a P-site substrate and puromycin as an A-site substrate. Steady-state kinetic analysis shows that oxazolidinones display a competitive inhibition pattern with respect to both the P-site and A-site substrates. This is consistent with a rapid equilibrium, ordered mechanism of the peptidyltransferase reaction, wherein binding of the A-site substrate can occur only after complex formation between peptidyltransferase and the P-site substrate. We propose that oxazolidinones inhibit bacterial protein biosynthesis by interfering with the binding of initiator fMet-tRNA(i)(Met) to the ribosomal peptidyltransferase P-site, which is vacant only prior to the formation of the first peptide bond.

Drug Interactions↗

PubMed2001

[Pharmacy attention to prescriptions in order to bring practice into line with scientific evidence].

OBJECTIVE: The objective of this study is to assess the usefulness of a programme of attention to pharmaceutical prescriptions (APP) so as to detect medicine-related problems. DESIGN: A descriptive study of the findings after six months operation of this programme. SETTING: Five primary care centres in the Bahía-Cádiz Area. PATIENTS: All the patients (499) who requested advice on their drug therapy and were included at the request and on the criterion of their doctor were studied. INTERVENTION: We introduced the APP programme for chronic patients, with two basic aims: Care: to detect medicine-related problems and propose individual solutions. Teaching: to bring drug-therapy skills used in clinical practice into line with the scientific evidence available. MEASUREMENTS AND RESULTS: We focused on the detection of problems related to the most common medicines, with direct and relevant incidence on morbidity and mortality. We detected 236 cases (47%) of possible therapeutic improvement that had important implications for associated morbidity, of which 114 (23%) also had implications for mortality. 56% of the patients took more than 4 medicines, multiple medication that could easily be reduced in 43.5% of cases, so avoiding the use of medicines of low intrinsic value. CONCLUSIONS: The programme was very useful, as numerous very clinically relevant problems were detected and information was gained that the doctor can use to bring drug therapy into line with the available scientific evidence.

Drug Interactions↗